Subscribe
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
SABCS 2023 - HER2+ MBC
ASCO 2023 - Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quizzes
Press Releases
AVBCC
Association for Value-Based Cancer Care
VBCM
Value-Based Care in Myeloma
Policies & Guidelines
Filter by Topic
Best Practices
Clinical Guidelines
End-of-Life Care
Health Policy
NCCN 2015 Updates
NCCN Guidelines
Pathways
Patient Advocacy
Patient Navigation
Quality Care
Survivorship
Survivorship Care
AMA Calls for More Transparency in Patient Navigation Programs
By
Caroline Helwick
Patient Navigation
,
Policies & Guidelines
December 2011, Vol 2, No 7
The House of Delegates of the American Medical Association (AMA) laid out guidelines for patient navigator programs during their November 2011 Interim Meeting. The aim is to ensure that patient navigators “enhance, rather than undermine, the delivery of high-quality patient care,” the resolution states.
Read Article
Medical Staff Members Spend Many Hours Dealing with Insurance Companies
By
Caroline Helwick
Health Policy
,
Policies & Guidelines
December 2011, Vol 2, No 7
Medical practices in the United States spend much more money and time dealing with third-party payers than do Canadian practices, according to a recent report (Morra D, et al. Health Aff. 2011;30:1443-1450).
Read Article
GPCI, or “GYPSY”: Calculated or Covert Cuts to Oncology Reimbursement
By
Robert Gamble
Health Policy
,
Policies & Guidelines
December 2011, Vol 2, No 7
Read Article
Frontier Cancer Care in Montana on the Leading Edge of Patient Care
Best Practices
,
Policies & Guidelines
December 2011, Vol 2, No 7
Interview with Patrick Cobb, MD, FACP
Read Article
Recent Ruling on Genetic Patents Leaves Many Questions
By
Rosemary Frei, MSc
Health Policy
,
Policies & Guidelines
October 2011, Vol 2, No 6
On July 29, 2011, a 3-judge panel from the US Court of Appeals for the Federal Circuit invalidated some patents held by Myriad Genetics and the University of Utah Research Foundation for methods of analyzing individuals’ gene sequences for the presence of BRCA1 and BRCA2 mutations, but upheld other related patents in a reversal of a lower court ruling.
Read Article
Survivorship Programs an Emerging Need, But Are They Cost-Effective?
By
Caroline Helwick
Policies & Guidelines
,
Survivorship Care
October 2011, Vol 2, No 6
The population of cancer survivors is rapidly growing. More than 12 million Americans are alive after a cancer diagnosis: most are living at least 5 years and 16% are alive 20 years after diagnosis.
Read Article
AACR Urges Congress to Increase Funding for the NIH and NCI
Health Policy
,
Policies & Guidelines
October 2011, Vol 2, No 6
In September 2011, the American Association of Cancer Research (AACR) issued a new report, “AACR Cancer Progress Report 2011” on the current state of cancer research and the implications of recent cuts in funding for the National Institutes of Health (NIH) and the National Cancer Institute (NCI).
Read Article
US Preventive Services Task Force and the Future of Prostate Cancer Screening
By
Ross D. Margulies, JD, MPH
;
Jayson Slotnik, JD, MPH
Health Policy
,
Policies & Guidelines
October 2011, Vol 2, No 6
The decision this month (October 2011) by the US Preventive Services Task Force (USPSTF) to recommend against a prostate-specific antigen (PSA)-based screening for prostate cancer in healthy men
1
has caused quite a stir both in and outside of medical circles, reminding many people of the task force’s 2009 recommendation against routine breast cancer screenings for women under age 50 years.
Read Article
Accountable Care Organizations: Implications for Cancer-Related Quality Care and Spending
By
Caroline Helwick
Health Policy
,
Policies & Guidelines
August 2011, Vol 2, No 5
ACOs are believed to hold the potential for addressing variation in quality and costs of cancer care, but their impact will depend on buy-in and leadership among oncologists, according to David Miller, MD, MPH, a urologic surgeon and health services researcher at the University of Michigan, Ann Arbor. He addressed this topic during the recent annual meeting of the American Society of Clinical Oncologists.
Read Article
Hanging in Limbo: What Does Deficit Reduction Mean for Oncology?
By
Ross D. Margulies, JD, MPH
;
Jayson Slotnik, JD, MPH
Health Policy
,
Policies & Guidelines
August 2011, Vol 2, No 5
On August 2, 2011, President Obama signed the Budget Control Act of 2011 into law, the result of a month-long partisan battle over raising the federal debt ceiling and, in the long-term, reducing the federal deficit (Budget ControlAct of 2011. Pub. L. No. 112-25).
Read Article
Page 9 of 11
2
3
4
5
6
7
8
9
10
11
View the Latest Issue of VBCC
Read Issue
Top Trending Articles
1.
Medication Assurance Programs, as Deceiving and Harmful as Alternate Funding Programs
Dawn Holcombe, MBA, FACMPE, ACHE
2.
Addressing Challenges to Adoption of Value-Based Agreements
Phoebe Starr
3.
Luspatercept Yields Improved Transfusion Independence Compared With Epoetin Alfa in Patients With Lower-Risk MDS
Phoebe Starr
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
SABCS 2023 - HER2+ MBC
ASCO 2023 - Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quizzes
Press Releases
AVBCC
Association for Value-Based Cancer Care
VBCM
Value-Based Care in Myeloma